August 12, 2020 at 04:16PM Civil Money Penalties Relating to the ClinicalTrials.gov Data Bank

The guidance describes the circumstances under which FDA may decide to seek civil money penalties for non-compliance, the applicable procedures for assessing civil money penalties, and the civil money penalty amounts that may be assessed for violations related to ClinicalTrials.gov requirements

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/35GYTwP